SGLT2 Inhibitors Market is Projected to Reach US$ 32.75 Billion by 2034, Registering a CAGR of 6.9%
The worldwide escalation in type 2 diabetes is driving the market demand.
SGLT2 inhibitors operate by decreasing renal entrance for glucose, causing elevated urinary glucose elimination.โ
NEW YORK CITY, NY, UNITED STATES, December 2, 2024 /EINPresswire.com/ -- Our SGLT2 inhibitors market report has been prepared using advanced methodologies and research techniques to help businesses make strategic business decisions.โ Polaris Market Research
The most recent research study by Polaris Market Research reveals that the SGLT2 inhibitors market is anticipated to flourish at a stable rate. With a projected CAGR of 6.9%, the market was valued at USD 16.79 billion in 2024. It is ready to grow to USD 32.75 billion by 2034.
๐๐๐ซ๐ค๐๐ญ ๐๐ง๐ญ๐ซ๐จ๐๐ฎ๐๐ญ๐ข๐จ๐ง:
Sodium-glucose cotransporter-2 (SGLT2) inhibitors are a category of oral prescription medicines that are FDA-consented for usage with diet and exercise to lessen blood sugar in grown-ups with type 2 diabetes. Some SGLT2 inhibitors are also FDA-consented for usage in people with chronic kidney disease (CKD) or heart failure to lessen the probability of heart attack, stroke, or heart failure involving people who are diabetes-free.
๐๐จ๐ฐ๐ง๐ฅ๐จ๐๐ ๐ ๐ซ๐๐ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ ๐๐จ๐ฉ๐ฒ ๐จ๐ ๐ญ๐ก๐ ๐๐๐ฉ๐จ๐ซ๐ญ:
https://www.polarismarketresearch.com/industry-analysis/sglt2-inhibitors-market/request-for-sample?utm_source=EIN&utm_medium=EIN&utm_campaign=EIN&utm_id=01
One kind of SGLT2 inhibitor is now FDA consented to assist in enhancing blood sugar regulation in children 10 years or above with type 2 diabetes. Research is in progress to observe if SGLT2 inhibitors are of assistance in some kidney illnesses in children who do not have diabetes. The growing consciousness of improved diagnostic methods has caused a superior aggregate of diabetes diagnoses, pushing the SGLT2 inhibitors market demand.
๐๐๐ฒ ๐๐จ๐ฆ๐ฉ๐๐ง๐ข๐๐ฌ ๐ข๐ง ๐๐๐๐๐ ๐๐ง๐ก๐ข๐๐ข๐ญ๐จ๐ซ๐ฌ ๐๐๐ซ๐ค๐๐ญ:
โข AstraZeneca
โข Boehringer Ingelheim International GmbH
โข Bristol-Myers Squibb Company
โข Eli Lilly and Company
โข Glenmark Pharmaceuticals Ltd.
โข Johnson & Johnson Services, Inc. (Janssen Pharmaceuticals, Inc.)
โข Lexicon Pharmaceuticals, Inc.
โข Merck & Co., Inc.
โข Sanofi
โข TheracosBio, LLC
๐๐๐ซ๐ค๐๐ญ ๐๐ซ๐ข๐ฏ๐๐ซ๐ฌ ๐๐ง๐ ๐๐ฉ๐ฉ๐จ๐ซ๐ญ๐ฎ๐ง๐ข๐ญ๐ข๐๐ฌ:
Clinical Guidelines and Recommendations: The clinical directives and advice of spearheading health firms such as the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) continuously reinforce the usage of SGLT2 inhibitors for particular patient categories. This approval has created the surge of SGLT2 inhibitors boosting the demand for SGLT2 inhibitors market growth.
Growing Geriatric Population: The growing geriatric population globally is causing the surging occurrence of diabetes and connected health conditions. Because of age-connected elements, elderly people are at an elevated probability of advancing type 2 diabetes, causing a profound requirement for SGLT2 inhibitors.
Surge in New Drug Approvals: The augmentation of the market is impacted by the consent of contemporary drugs and enlarged symptoms by administrative organizations such as the FDA and EMA. SGLT2 inhibitors, acknowledged for their medicinal applications, have acquired growing consent for additional symptoms involving type 2 diabetes, heart failure, and chronic kidney disease.
๐๐๐ช๐ฎ๐๐ฌ๐ญ ๐๐จ๐ซ ๐ ๐๐ข๐ฌ๐๐จ๐ฎ๐ง๐ญ ๐จ๐ง ๐ญ๐ก๐ข๐ฌ ๐๐๐ฉ๐จ๐ซ๐ญ ๐๐๐๐จ๐ซ๐ ๐๐ฎ๐ซ๐๐ก๐๐ฌ๐:
https://www.polarismarketresearch.com/industry-analysis/sglt2-inhibitors-market/request-for-discount-pricing?utm_source=EIN&utm_medium=EIN&utm_campaign=EIN&utm_id=01
๐๐๐ ๐ฆ๐๐ง๐ญ๐๐ฅ ๐๐ง๐๐ฅ๐ฒ๐ฌ๐ข๐ฌ:
โข The SGLT2 inhibitors market segmentation is based on indication, drug, distribution channel, and region.
โข By indication analysis, the type 2 diabetes segment held the largest market share. This is due to the increasing existence of obesity emanating from substandard dietary options, indolent lifestyles, and elevated calorie food consumption. Contemporary lifestyles normally include extended periods of physical idleness pushed by desk-bound work, escalated screen times, and decreased physical strain.
โข By distribution channel analysis, the online pharmacies segment is poised to register a significant CAGR. This is due to them offering exceptional ease to patients particularly those in distant and underserved areas. This augmented penetration has caused a growing market reach of SGLT2 inhibitors, rendering them more broadly obtainable.
๐๐๐ ๐ข๐จ๐ง๐๐ฅ ๐๐ฏ๐๐ซ๐ฏ๐ข๐๐ฐ:
The research report covers all the major regions and sub-regions of the SGLT2 inhibitors market. The study provides market insights into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
North America: North America accounted for the largest market share. This is primarily because of growing detrimental strain and inadequate mental health. Further, the growing existence of diabetes patients in North America has caused elevated demand for SGLT2 inhibitors in the region.
Asia Pacific: Asia Pacific is anticipated to witness the fastest CAGR from 2024 to 2032. The region's growing aging population, causing an elevated existence of type 2 diabetes among older grownups, fuels the regional market expansion.
๐๐ง๐ช๐ฎ๐ข๐ซ๐ ๐ฆ๐จ๐ซ๐ ๐๐๐จ๐ฎ๐ญ ๐ญ๐ก๐ข๐ฌ ๐๐๐ฉ๐จ๐ซ๐ญ ๐๐๐๐จ๐ซ๐ ๐๐ฎ๐ซ๐๐ก๐๐ฌ๐:
https://www.polarismarketresearch.com/industry-analysis/sglt2-inhibitors-market/inquire-before-buying?utm_source=EIN&utm_medium=EIN&utm_campaign=EIN&utm_id=01
๐ ๐๐๐ฌ:
How much is the SGLT2 inhibitors market?
The market size was valued at USD 16.79 billion in 2024 and is expected to reach USD 32.75 billion by 2034.
What is the growth rate of the SGLT2 inhibitors market?
The global market is projected to register a CAGR of 6.9% during the forecast period 2025-2034.
Which region held the largest market share?
North America had the largest share of the global market in 2024.
Which indication led the market in 2024?
The type 2 diabetes category dominated the market in 2024.
๐๐ซ๐จ๐ฐ๐ฌ๐ ๐๐๐'๐ฌ ๐๐๐๐๐ ๐๐ง๐ก๐ข๐๐ข๐ญ๐จ๐ซ๐ฌ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ฉ๐จ๐ซ๐ญ ๐๐จ๐ฏ๐๐ซ๐๐ ๐ ๐๐ซ๐จ๐ฆ ๐๐ข๐๐๐๐ซ๐๐ง๐ญ ๐๐ฎ๐๐ฅ๐ข๐๐๐ญ๐ข๐จ๐ง๐ฌ:
SGLT2 Inhibitors Industry is growing at a CAGR of 6.9% in the forecast period (2025-2034)
๐๐ซ๐จ๐ฐ๐ฌ๐ ๐๐จ๐ซ๐ ๐๐๐ฌ๐๐๐ซ๐๐ก ๐๐๐ฉ๐จ๐ซ๐ญ๐ฌ:
Metastatic Lung Adenocarcinoma Treatment Market:
https://www.polarismarketresearch.com/industry-analysis/metastatic-lung-adenocarcinoma-treatment-market
Medical Batteries Market:
https://www.polarismarketresearch.com/industry-analysis/medical-batteries-market
In Vitro Diagnostics Market:
https://www.polarismarketresearch.com/industry-analysis/in-vitro-diagnostics-market
Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) Market:
https://www.polarismarketresearch.com/industry-analysis/blastic-plasmacytoid-dendritic-cell-neoplasm-market
DNA Diagnostics Market:
https://www.polarismarketresearch.com/industry-analysis/dna-diagnostics-market
US Organoids and Spheroids Market:
https://www.polarismarketresearch.com/industry-analysis/us-organoids-and-spheroids-market
๐๐๐จ๐ฎ๐ญ ๐๐จ๐ฅ๐๐ซ๐ข๐ฌ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ฌ๐๐๐ซ๐๐ก & ๐๐จ๐ง๐ฌ๐ฎ๐ฅ๐ญ๐ข๐ง๐ , ๐๐ง๐:
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for PMRโs clientele spread across different enterprises. We at Polaris are obliged to serve PMRโs diverse customer base present across the industries of healthcare, technology, semiconductors, and chemicals among various other industries present around the world. We strive to provide PMRโs customers with updated information on innovative technologies, high-growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to PMRโs customers.
Likhil G
Polaris Market Research and Consulting
+1 929-297-9727
sales@polarismarketresearch.com
Visit us on social media:
Facebook
X
LinkedIn
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
